Request Demo
Last update 08 May 2025
Agkistrodon hyalys Antivenin(Jiangxi Institute of Biological Products)
Last update 08 May 2025
Overview
Basic Info
Drug Type Antitoxin |
Synonyms- |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
1
Clinical Trials associated with Agkistrodon hyalys Antivenin(Jiangxi Institute of Biological Products)CTR20251549
一项单中心、随机、双盲、平行对照、剂量递增的I期临床研究，评价抗蝮蛇毒血清单次给药在健康成年受试者中的安全性、耐受性及药代动力学特征。
[Translation] This is a single-center, randomized, double-blind, parallel-controlled, dose-escalation phase I clinical study to evaluate the safety, tolerability and pharmacokinetic characteristics of a single dose of antivenom in healthy adult subjects.
100 Clinical Results associated with Agkistrodon hyalys Antivenin(Jiangxi Institute of Biological Products)
Login to view more data
100 Translational Medicine associated with Agkistrodon hyalys Antivenin(Jiangxi Institute of Biological Products)
Login to view more data
100 Patents (Medical) associated with Agkistrodon hyalys Antivenin(Jiangxi Institute of Biological Products)
Login to view more data
100 Deals associated with Agkistrodon hyalys Antivenin(Jiangxi Institute of Biological Products)
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Snake Bites | Phase 1 | China | 22 Apr 2025 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Biosimilar
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free